Literature DB >> 25643846

Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels.

Sheida Moghadamrad1, Kathy D McCoy, Markus B Geuking, Hans Sägesser, Jorum Kirundi, Andrew J Macpherson, Andrea De Gottardi.   

Abstract

UNLABELLED: Intestinal bacterial flora may induce splanchnic hemodynamic and histological alterations that are associated with portal hypertension (PH). We hypothesized that experimental PH would be attenuated in the complete absence of intestinal bacteria. We induced prehepatic PH by partial portal vein ligation (PPVL) in germ-free (GF) or mice colonized with altered Schaedler's flora (ASF). After 2 or 7 days, we performed hemodynamic measurements, including portal pressure (PP) and portosystemic shunts (PSS), and collected tissues for histomorphology, microbiology, and gene expression studies. Mice colonized with intestinal microbiota presented significantly higher PP levels after PPVL, compared to GF, mice. Presence of bacterial flora was also associated with significantly increased PSS and spleen weight. However, there were no hemodynamic differences between sham-operated mice in the presence or absence of intestinal flora. Bacterial translocation to the spleen was demonstrated 2 days, but not 7 days, after PPVL. Intestinal lymphatic and blood vessels were more abundant in colonized and in portal hypertensive mice, as compared to GF and sham-operated mice. Expression of the intestinal antimicrobial peptide, angiogenin-4, was suppressed in GF mice, but increased significantly after PPVL, whereas other angiogenic factors remained unchanged. Moreover, colonization of GF mice with ASF 2 days after PPVL led to a significant increase in intestinal blood vessels, compared to controls. The relative increase in PP after PPVL in ASF and specific pathogen-free mice was not significantly different.
CONCLUSION: In the complete absence of gut microbial flora PP is normal, but experimental PH is significantly attenuated. Intestinal mucosal lymphatic and blood vessels induced by bacterial colonization may contribute to development of PH.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25643846     DOI: 10.1002/hep.27698

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Authors:  Juan P Arab; Rosa M Martin-Mateos; Vijay H Shah
Journal:  Hepatol Int       Date:  2017-05-26       Impact factor: 6.047

2.  Gut microbiota regulates lacteal integrity by inducing VEGF-C in intestinal villus macrophages.

Authors:  Sang Heon Suh; Kibaek Choe; Seon Pyo Hong; Seung-Hwan Jeong; Taija Mäkinen; Kwang Soon Kim; Kari Alitalo; Charles D Surh; Gou Young Koh; Joo-Hye Song
Journal:  EMBO Rep       Date:  2019-02-19       Impact factor: 8.807

Review 3.  Intestinal Flora: A Potential New Regulator of Cardiovascular Disease.

Authors:  Yifei Zou; Xianjing Song; Ning Liu; Wei Sun; Bin Liu
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 4.  The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.

Authors:  Tao Yang; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

Review 5.  Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.

Authors:  Roshan Kumar; Utkarsh Sood; Vipin Gupta; Mona Singh; Joy Scaria; Rup Lal
Journal:  Indian J Microbiol       Date:  2019-05-25       Impact factor: 2.461

Review 6.  Immunity, microbiota and kidney disease.

Authors:  Felix Knauf; J Richard Brewer; Richard A Flavell
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

7.  Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.

Authors:  Monika Schaubeck; Thomas Clavel; Jelena Calasan; Ilias Lagkouvardos; Sven Bastiaan Haange; Nico Jehmlich; Marijana Basic; Aline Dupont; Mathias Hornef; Martin von Bergen; André Bleich; Dirk Haller
Journal:  Gut       Date:  2015-04-17       Impact factor: 23.059

8.  Gut microbiota dysbiosis contributes to the development of hypertension.

Authors:  Jing Li; Fangqing Zhao; Yidan Wang; Junru Chen; Jie Tao; Gang Tian; Shouling Wu; Wenbin Liu; Qinghua Cui; Bin Geng; Weili Zhang; Ryan Weldon; Kelda Auguste; Lei Yang; Xiaoyan Liu; Li Chen; Xinchun Yang; Baoli Zhu; Jun Cai
Journal:  Microbiome       Date:  2017-02-01       Impact factor: 14.650

9.  Novel treatment options for portal hypertension.

Authors:  Philipp Schwabl; Wim Laleman
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18

10.  Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.

Authors:  Susanne H Karbach; Tanja Schönfelder; Ines Brandão; Eivor Wilms; Nives Hörmann; Sven Jäckel; Rebecca Schüler; Stefanie Finger; Maike Knorr; Jeremy Lagrange; Moritz Brandt; Ari Waisman; Sabine Kossmann; Katrin Schäfer; Thomas Münzel; Christoph Reinhardt; Philip Wenzel
Journal:  J Am Heart Assoc       Date:  2016-08-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.